Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine for Hepatoprotection in Liver Resection
NCT00845689Phase 2Unknown
- Sponsor
- Ludwig Maximilian University of Munich
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 2 trial of adenosine in liver ischemia-reperfusion injury, sponsored by Ludwig Maximilian University of Munich. Status: unknown.
02
Drugs
adenosine
03
Conditions
liver ischemia-reperfusion injury
Beyond the preview
Go deeper on NCT00845689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845689.